NIH #UH2CA307747
A multimodal liquid biopsy assay to quantify androgen receptor’s somatic alterations in metastatic castration-resistant prostate cancer.
Active
- Amount
- $200K–$300K
- Period
- 2026-03-16 → 2028-02-29
- PIs
- 2
Awarded at H. LEE MOFFITT CANCER CTR & RES INST